STOCK TITAN

Applied UV Declares Monthly Preferred Stock Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary

Applied UV (NasdaqCM: AUVI) announced a cash dividend of $0.21875 per share for its 10.5% Series A Cumulative Perpetual Preferred Stock, set to be paid on February 15, 2022, to shareholders recorded by February 4, 2022. The company specializes in pathogen elimination technology, leveraging UVC light and catalytic bioconversion for air purification. The announcement underscores Applied UV's commitment to providing shareholder returns while reinforcing its focus on infection control across diverse markets including healthcare and hospitality.

Positive
  • Authorized a cash dividend of $0.21875 per share for preferred stockholders.
  • Demonstrates commitment to providing returns to shareholders.
  • Focus on innovative pathogen elimination technologies may enhance market position.
Negative
  • Dependence on preferred stock dividends could strain cash reserves.
  • -

MOUNT VERNON, NY / ACCESSWIRE / January 25, 2022 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the cash dividend to holders of Applied UV's 10.5% Series A Cumulative Perpetual Preferred Stock.

Holders of the 10.5% Series A Cumulative Perpetual Preferred Stock (Nasdaq:AUVIP) shall receive a cash dividend equal to $0.21875 per share.

The preferred dividend will be paid on or about February 15, 2022, to respective holders of record at the close of business on February 4, 2022.

About Applied UV

Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen's connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company's Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® products for air purification, developed for NASA and FDA Cleared as class II medical devices, utilize a proprietary photo-catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs and biological gasses into harmless water vapor without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, and homes.

For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites: https://www.applieduvinc.com/; https://sterilumen.com/; https://www.airocide.com https://kesscience.com; https://scientificairmanagement.com and, https://munnworks.com/.

Forward-Looking Statements

The information contained herein may contain "forward‐looking statements." Forward‐looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward‐looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward‐looking statements to conform these statements to actual results.

For additional Company Information:

Applied UV Inc.
Max Munn
Applied UV Interim CEO
m.munn@sterilumen.com

Applied UV Investor Relations
Kevin McGrath

TraDigital IR
+1-646-418-7002
kevin@tradigitalir.com

SOURCE: Applied UV Inc.



View source version on accesswire.com:
https://www.accesswire.com/685201/Applied-UV-Declares-Monthly-Preferred-Stock-Dividend

FAQ

What is the dividend amount for Applied UV (AUVI) preferred stock?

Applied UV has declared a cash dividend of $0.21875 per share for its 10.5% Series A Cumulative Perpetual Preferred Stock.

When will the dividend for AUVI be paid?

The dividend will be paid on or about February 15, 2022.

Who is eligible to receive the dividend from Applied UV?

Holders of record at the close of business on February 4, 2022, are eligible to receive the dividend.

How does the dividend impact shareholders of AUVI?

The dividend provides a steady return to shareholders, indicating the company's commitment to shareholder value.

What is the significance of the 10.5% Series A Cumulative Perpetual Preferred Stock?

This preferred stock offers a fixed dividend, which can provide stable income for investors.

Applied UV, Inc.

NASDAQ:AUVI

AUVI Rankings

AUVI Latest News

AUVI Stock Data

1.37M
4.67M
1.53%
6.19%
1.93%
Furnishings, Fixtures & Appliances
Electric Lighting & Wiring Equipment
Link
United States of America
MOUNT VERNON